New aspects of copper and iron metabolism in the myelodysplastic syndromes

J. Várkonyi, Terézia Szabó, Piroska Sebestyén, A. Tordai, H. Andrikovics, Géza Kollai, I. Karádi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Myelodysplastic syndrome (MDS) is an iron overload condition. Copper deficiency itself might induce dysplastic changes and iron overload. The relationship between the iron and copper metabolism is analyzed in MDS patients. Methods: Copper, iron and ceruloplasmin levels were established, and transferrin saturation determination and HFE mutation analysis were performed in 32 MDS patients. Results: Eleven of 32 MDS patients were copper deficient. A decreased copper level occurred together with a significantly elevated iron level and transferrin saturation and in 45% HFE gene mutation. In the normal copper group, twice as many patients had a decreased rather than an elevated iron content and carried the wild-type HFE gene rather than the mutant. Conclusions: Copper deficiency is a frequent finding in MDS. It is desirable to include copper level determination in the initial workup of MDS.

Original languageEnglish
Pages (from-to)66-68
Number of pages3
JournalChemotherapy
Volume52
Issue number2
DOIs
Publication statusPublished - Apr 2006

Fingerprint

Myelodysplastic Syndromes
Copper
Iron
Iron Overload
Transferrin
Mutation
Ceruloplasmin
Genes

Keywords

  • Copper
  • HFE gene mutation
  • Iron
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

New aspects of copper and iron metabolism in the myelodysplastic syndromes. / Várkonyi, J.; Szabó, Terézia; Sebestyén, Piroska; Tordai, A.; Andrikovics, H.; Kollai, Géza; Karádi, I.

In: Chemotherapy, Vol. 52, No. 2, 04.2006, p. 66-68.

Research output: Contribution to journalArticle

Várkonyi, J. ; Szabó, Terézia ; Sebestyén, Piroska ; Tordai, A. ; Andrikovics, H. ; Kollai, Géza ; Karádi, I. / New aspects of copper and iron metabolism in the myelodysplastic syndromes. In: Chemotherapy. 2006 ; Vol. 52, No. 2. pp. 66-68.
@article{48d8f1208e5a41929b9ab001dff1c91d,
title = "New aspects of copper and iron metabolism in the myelodysplastic syndromes",
abstract = "Background: Myelodysplastic syndrome (MDS) is an iron overload condition. Copper deficiency itself might induce dysplastic changes and iron overload. The relationship between the iron and copper metabolism is analyzed in MDS patients. Methods: Copper, iron and ceruloplasmin levels were established, and transferrin saturation determination and HFE mutation analysis were performed in 32 MDS patients. Results: Eleven of 32 MDS patients were copper deficient. A decreased copper level occurred together with a significantly elevated iron level and transferrin saturation and in 45{\%} HFE gene mutation. In the normal copper group, twice as many patients had a decreased rather than an elevated iron content and carried the wild-type HFE gene rather than the mutant. Conclusions: Copper deficiency is a frequent finding in MDS. It is desirable to include copper level determination in the initial workup of MDS.",
keywords = "Copper, HFE gene mutation, Iron, Myelodysplastic syndrome",
author = "J. V{\'a}rkonyi and Ter{\'e}zia Szab{\'o} and Piroska Sebesty{\'e}n and A. Tordai and H. Andrikovics and G{\'e}za Kollai and I. Kar{\'a}di",
year = "2006",
month = "4",
doi = "10.1159/000091307",
language = "English",
volume = "52",
pages = "66--68",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - New aspects of copper and iron metabolism in the myelodysplastic syndromes

AU - Várkonyi, J.

AU - Szabó, Terézia

AU - Sebestyén, Piroska

AU - Tordai, A.

AU - Andrikovics, H.

AU - Kollai, Géza

AU - Karádi, I.

PY - 2006/4

Y1 - 2006/4

N2 - Background: Myelodysplastic syndrome (MDS) is an iron overload condition. Copper deficiency itself might induce dysplastic changes and iron overload. The relationship between the iron and copper metabolism is analyzed in MDS patients. Methods: Copper, iron and ceruloplasmin levels were established, and transferrin saturation determination and HFE mutation analysis were performed in 32 MDS patients. Results: Eleven of 32 MDS patients were copper deficient. A decreased copper level occurred together with a significantly elevated iron level and transferrin saturation and in 45% HFE gene mutation. In the normal copper group, twice as many patients had a decreased rather than an elevated iron content and carried the wild-type HFE gene rather than the mutant. Conclusions: Copper deficiency is a frequent finding in MDS. It is desirable to include copper level determination in the initial workup of MDS.

AB - Background: Myelodysplastic syndrome (MDS) is an iron overload condition. Copper deficiency itself might induce dysplastic changes and iron overload. The relationship between the iron and copper metabolism is analyzed in MDS patients. Methods: Copper, iron and ceruloplasmin levels were established, and transferrin saturation determination and HFE mutation analysis were performed in 32 MDS patients. Results: Eleven of 32 MDS patients were copper deficient. A decreased copper level occurred together with a significantly elevated iron level and transferrin saturation and in 45% HFE gene mutation. In the normal copper group, twice as many patients had a decreased rather than an elevated iron content and carried the wild-type HFE gene rather than the mutant. Conclusions: Copper deficiency is a frequent finding in MDS. It is desirable to include copper level determination in the initial workup of MDS.

KW - Copper

KW - HFE gene mutation

KW - Iron

KW - Myelodysplastic syndrome

UR - http://www.scopus.com/inward/record.url?scp=33646120333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646120333&partnerID=8YFLogxK

U2 - 10.1159/000091307

DO - 10.1159/000091307

M3 - Article

VL - 52

SP - 66

EP - 68

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 2

ER -